Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases
JACC CardioOncol
.
2024 Nov 12;6(6):982-984.
doi: 10.1016/j.jaccao.2024.09.008.
eCollection 2024 Dec.
Authors
Isabel G Scalia
1
,
Mohamad Bassam Sonbol
2
,
Juan M Farina
1
,
Milagros Pereyra
1
,
Yuxiang Wang
1
,
Tanios S Bekaii-Saab
2
,
Ming Yang
3
,
Heidi M Connolly
4
,
Patricia A Pellikka
4
,
Joerg Herrmann
4
,
Thorvardur R Halfdanarson
5
,
Jason S Starr
6
,
Sushil Allen Luis
4
,
Reza Arsanjani
1
,
Chadi Ayoub
1
Affiliations
1
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
2
Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.
3
Department of Radiology, Mayo Clinic, Phoenix, Arizona, USA.
4
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
5
Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
6
Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.
PMID:
39801630
PMCID:
PMC11712006
DOI:
10.1016/j.jaccao.2024.09.008
No abstract available
Keywords:
cardiac masses; nuclear imaging; outcomes.